Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
8.62M |
$68.9M |
$8.00 |
Feb 27, 2023 |
By Flagship Pioneering Fund VI, L.P. |
Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
7.51M |
$60.1M |
$8.00 |
Feb 27, 2023 |
By Flagship Pioneering Special Opportunities Fund II, L.P. |
Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
5.9M |
$47.2M |
$8.00 |
Feb 27, 2023 |
By Flagship Ventures Fund V, L.P. |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
8.62M |
$34.5M |
$4.00 |
Sep 13, 2023 |
By Flagship VentureLabs V, LLC |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
8.06M |
$32.2M |
$4.00 |
Sep 13, 2023 |
By Flagship Ventures Fund V, L.P. |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
7.29M |
$29.2M |
$4.00 |
Sep 13, 2023 |
By Flagship Pioneering Fund VI, L.P. |
Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
2.2M |
$17.6M |
$8.00 |
Feb 27, 2023 |
By Flagship VentureLabs V, LLC |
Sana Biotechnology, Inc. |
10%+ Owner |
Pre-Funded Warrants to purchase Common Stock |
2.73M |
$15M |
$5.50 |
Feb 12, 2024 |
By Flagship Pioneering Fund VII, L.P. |
Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
1.62M |
$12.9M |
$8.00 |
Feb 27, 2023 |
By FPN, L.P. |
Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
1.62M |
$12.9M |
$8.00 |
Aug 3, 2021 |
Indirect |
Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
1.33M |
$10.6M |
$8.00 |
Feb 27, 2023 |
By Flagship Pioneering Fund VII, L.P. |
Foghorn Therapeutics Inc. |
10%+ Owner |
Pre-Funded Warrants to purchase Common Stock |
1.81M |
$10M |
$5.51 |
May 22, 2024 |
By Flagship Pioneering Fund VII, L.P. |
Foghorn Therapeutics Inc. |
10%+ Owner |
Pre-Funded Warrants to purchase Common Stock |
1.81M |
$10M |
$5.51 |
May 22, 2024 |
By Flagship Pioneering Special Opportunities Fund II, L.P. |
Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
1.09M |
$8.71M |
$8.00 |
Feb 27, 2023 |
By Flagship V VentureLabs Rx Fund, L.P. |
Omega Therapeutics, Inc. |
10%+ Owner |
Common Stock |
971K |
$7.76M |
$8.00 |
Feb 27, 2023 |
By Nutritional Health LTP Fund, L.P. |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
1.04M |
$4.14M |
$4.00 |
Sep 13, 2023 |
By Flagship V VentureLabs Rx Fund, L.P. |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
582K |
$2.33M |
$4.00 |
Sep 13, 2023 |
Indirect |
Axcella Health Inc. |
10%+ Owner |
Common Stock |
3.05M |
$1.77M |
$0.58 |
Oct 13, 2022 |
By FPA, L.P. |
Omega Therapeutics, Inc. |
10%+ Owner |
Series A Convertible Preferred Stock |
0 |
|
|
Aug 3, 2021 |
Indirect |
Omega Therapeutics, Inc. |
10%+ Owner |
Series B Convertible Preferred Stock |
0 |
|
|
Aug 3, 2021 |
Indirect |
Omega Therapeutics, Inc. |
10%+ Owner |
Series C Convertible Preferred Stock |
0 |
|
|
Aug 3, 2021 |
Indirect |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$4.00 |
Sep 13, 2023 |
By Flagship Pioneering Fund VI General Partner LLC |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$4.00 |
Sep 13, 2023 |
By Flagship Ventures Fund V General Partner LLC |